title: The incidence of myocardial ischemia during anesthesia for coronary artery bypass surgery in patients receiving pancuronium or vecuronium.
abstract: This study was performed to compare the incidence of prebypass myocardial ischemia in patients receiving fentanyl and enflurane for anesthesia along with either pancuronium or vecuronium. Ninety-eight patients with normal left ventricular function were randomly allocated to receive either pancuronium 0.15 mg.kg-1 or vecuronium 0.15 mg.kg-1 in a double-blind manner after fentanyl 40 micrograms.kg-1 for induction of anesthesia for elective coronary artery bypass grafting (CABG). Premedication included diazepam 0.15 mg.kg-1 po, morphine 0.10 mg.kg-1, and scopolamine 0.005 mg.kg-1 im. Two lead Holter monitor recordings (leads V6 and V9) from the time of arrival in the operating suite to institution of cardiopulmonary bypass were analyzed for ischemia by a cardiologist blinded to the choice of muscle relaxant. Intraoperatively, heart rates greater than 90 beats.min-1 and systolic blood pressure +/- 20% of ward values were treated with propranolol, enflurane, or phenylephrine. Nitroglycerin was infused for ECG signs of ischemia or pulmonary hypertension. After induction of anesthesia the heart rate and cardiac index were consistently decreased in patients receiving vecuronium and also lower in these patients compared with those receiving pancuronium. Thirty-two per cent of patients receiving pancuronium received propranolol for heart rates greater than 90 beats.min-1 versus 7% of those who received vecuronium (P approximately 0.01). Eight patients developed 13 episodes of ischemia after administration of the muscle relaxant: four who received pancuronium (n = 44; 9%) and four receiving vecuronium (n = 54; 7%). Four episodes occurred at induction or tracheal intubation, two in each group. There were four perioperative myocardial infarctions as determined by ECG and CPK-MB levels, two in each group.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Anaesthesia, Royal Victoria Hospital, Montreal, Quebec, Canada.
authors.forename: J P
authors.initials: JP
authors.lastname: O'Connor
authors.forename: J G
authors.initials: JG
authors.lastname: Ramsay
authors.forename: J E
authors.initials: JE
authors.lastname: Wynands
authors.forename: F E
authors.initials: FE
authors.lastname: Ralley
authors.forename: W F
authors.initials: WF
authors.lastname: Casey
authors.forename: C E
authors.initials: CE
authors.lastname: Smith
authors.forename: G R
authors.initials: GR
authors.lastname: Robbins
authors.forename: J
authors.initials: J
authors.lastname: Bilodeau
authors.forename: M H
authors.initials: MH
authors.lastname: Sami
mesh_terms: D000769:Anesthesia, Inhalation; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000139:chemically induced*; D004311:Double-Blind Method; D004737:Enflurane; D005260:Female; D005283:Fentanyl; D006801:Humans; D008297:Male; D008875:Middle Aged; D010197:Pancuronium / Q000009:adverse effects*; D011897:Random Allocation; D014673:Vecuronium Bromide / Q000009:adverse effects*
chemical_list: D014673:Vecuronium Bromide; D004737:Enflurane; D010197:Pancuronium; D005283:Fentanyl